News

Advancing Care for Patients with Pancreatic Tumors with EUS‑RFA

Dr. Shailendra Singh: Director of Bariatric Endoscopy | Advanced Endoscopist | Associate Professor of Medicine, West

Read Blog

Endoscopic Ultrasound <br>Radiofrequency Ablation (EUS-RFA):

Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA):

In recent years, endoscopic ultrasound radiofrequency ablation (EUS-RFA) has emerged as a highly effective, minimally invasive approach to ablating soft...

Read Blog

Association of Women Endoscopists (AWE)

This annual educational program aims to promote the knowledge of recent and cutting-edge approaches in interventional GI, both in current...

Read Blog

American College of Gastroenterology (ACG) 2021

TaeWoong Medical USA was an exhibitor at the ACG 2021 Annual Meeting providing in-depth product demonstrations for Endoscopic RFA devices.

Hear the Podcast

Disclosures & Important Safety Information

Patients should talk to their doctor to decide if any TaeWoong Medical USA procedure is right for them. Patients and doctors should review all available information on non-surgical and surgical options and associated risks in order to make an informed decision.

Serious complications may occur in any surgery, including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use.

Individuals’ outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.

Taewoong

About Us
Events

Product

Endoscopic RFA
GI Stent
GI Accessories

Contact

Location
Global Network
Customer Service

X-twitter Linkedin

Terms of Use
·
Privacy Policy
·
Sitemap

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy